Clinical outcome and expression of mutant P53, P16, and Smad4 in lung adenocarcinoma: a prospective study
Chun'an Bian(Nanjing Medical University), Hongbing Shen(Nanjing Medical University)
Cited by 23
Related Papers
PI3K/AKT inhibition induces compensatory activation of the MET/STAT3 pathway in non‑small cell lung cancer
|Oncology Letters|2018|33
A causal variant rs3769823 in 2q33.1 involved in apoptosis pathway leading to a decreased risk of non-small cell lung cancer
|Cancer Biology and Medicine|2022|7